PerZeption Inc. Announces Collaboration with Alcon Research

PerZeption is set to present new data validating its AIM+ CSF modeling technology at the Association of Research in Vision and Ophthalmology (ARVO) annual meeting.

"We are very excited to collaborate with Alcon, one of the largest companies within the Ophthalmology sector worldwide. ", Dr. Jan Skerswetat said. "The results, presented by Dr Derek Nankivil, indicate that our technology enables rapid, repeatable, and highly sensitive assessment of contrast vision."

"In addition to all the exciting research presentations that leverage PerZeption technology at this years' ARVO meeting, we are also proud to be showcasing PerZeption's battery of functional tests at our booth, #4027." Dr. Skerswetat added and noted that there will be opportunities to try out our technology.